Why the study?
Adrenal tumor frequently requires adrenalectomy, but the safety, implementation, and health economic impact of enhanced recovery after surgery (ERAS) across open, laparoscopic, and robotic-assisted approaches remained to be compared.
Does the implementation of ERAS and minimally invasive surgery improve safety and health economics in patients undergoing adrenalectomy for adrenal tumors?
Does the implementation of ERAS and minimally invasive surgery improve safety and health economics in patients undergoing adrenalectomy for adrenal tumors?
The implementation of ERAS and minimally invasive surgery for adrenalectomy significantly reduces operating time, bleeding, and out-of-pocket expenses for patients.
Supports laparoscopic ERAS feasibility in adrenalectomy; leaves open need for RCTs to confirm benefits before practice change.
Background Adrenal tumor is a common condition that often requires adrenalectomy. The objective of this study is to compare the safety and implementation of the enhanced recovery after surgery (ERAS) among patients who received open, laparoscopic and robotic‐assisted operation. The impact of ERAS on health economics was also preliminarily evaluated. Methods This is a retrospective study using the electronic medical records of patients with adrenal tumor at the University of Hong Kong‐Shenzhen Hospital between January 2013 and December 2023. All the patients received partial or total adrenalectomy via different surgical approaches. Results A total of 254 participants were included in our study. Among them, 229 (90.2%) received laparoscopic adrenalectomy, 12 (4.7%) received robotic‐assisted operation, and 13 (5.1%) received open surgery. The majority of the patients' costs ( n = 200, 78.7%) were covered by national health insurance in China. The proportion of robotic surgery increased significantly over time ( p < 0.001). Laparoscopic surgery showed significantly shorter operating time and less bleeding than open surgery ( p < 0.001). Implementation of ERAS after surgery increased from 3% in 2013–2015 to 46% in 2022–2023 following the 4N protocol (no drainage, no antibiotics, no opioid analgesia, and no intravenous fluids). The out‐of‐pocket expenses for patients decreased from CNY 11 700 in 2013 to CNY 2700 in 2023. Conclusion The proportion of ERAS has increased. Despite increased total expenses, the out‐of‐pocket expenses for patients have significantly decreased over time via implementation of the ERAS approach.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: